JAMA Study Demonstrates Efficacy of Life Technologies' Lung Cancer Test
Published: Thursday, November 08, 2012 Last Updated: Thursday, November 08, 2012
Genetic test identifies patients at high risk for mortality in the earliest stage of lung cancer. Study suggests test could maximize the benefits of early screening if used in combination with computed tomography.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.